]nduction and Promotion of labor. Spontaneous vertex delivery
Conditions
Interventions
Intervention 1: Intervention group oxytocin with dose 2 mIU/min which increase every 15 min. Intervention 2: Intervention group oxytocin- propranolol, oxytocin with dose 2 mIU/min which increase every
Treatment - Drugs
Intervention group oxytocin with dose 2 mIU/min which increase every 15 min
Intervention group oxytocin- propranolol, oxytocin with dose 2 mIU/min which increase every 15 min and propranolol 2 mg/ml IV
Sponsors
Gorgan Congenital malformations research center, Golestan University of Medical Sciences,Gorgan, Ira
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: 37 to 41 weeks gestational age based on reliable LMP and ultrasound confirmation in the first quarter, also nuliparity; singleton, cephalic presentation;, intact membranes , bishop score equal to or less than 5. Exclusion criteria: CPD; any history of previous surgery on the uterus; fetal distress; the risk of macrosomia or polyhydramnius; SBP=100; PR=60; PR=120 min; any history of cardiopulmonary disease; known metabolic disease of mother or taking medicine for any illness in the mother.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The duration of phases of labor. Timepoint: Since the intervention untile delivery. Method of measurement: vaginal exam. | — |
Secondary
| Measure | Time frame |
|---|---|
| Neonate s Apgar. Timepoint: After Delivery. Method of measurement: According to the protocol.;Pregnancy ending in caesarean section. Timepoint: After the second period of injection. Method of measurement: Based on the indications for cesarean section. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Elaheh Amiri
Golestan University of Medical Sciences
Outcome results
None listed